EP2488033
Samsetning sem inniheldur MEK hindra og B-raf hindra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.10.2010EP published:
12.6.2019EP application number:
10824148.0
EP translation filed:
28.8.2019Grant published:
15.9.2019EPO information:
European Patent Register
Max expiry date:
14.10.2030Expiry date:
14.10.2026Next due date:
31.10.2026
Title:
Combination comprising an MEK inhibitor and a B-raf inhibitor
Timeline
Today
15.10.2010EP application
12.6.2019EP Publication
28.8.2019Translation submitted
15.9.2019Registration published
14.10.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
DUMBLE, MelissaAddress:
Collegeville, Pennsylvania, US
Name:
KUMAR, RakeshAddress:
Collegeville, Pennsylvania, US
Name:
LAQUERRE, SylvieAddress:
Collegeville, Pennsylvania, US
Name:
LEBOWITZ, PeterAddress:
Collegeville, Pennsylvania, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
252213 PDate:
16.10.2009Country:
US
Classification
Categories:
A61K 31/506, A61K 31/519, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 28.8.2019
Expires: 14.10.2020
Payer: Árnason Faktor
Number: 11
Paid: 24.9.2020
Expires: 14.10.2021
Payer: Árnason Faktor ehf.
Number: 12
Paid: 27.9.2021
Expires: 14.10.2022
Payer: Árnason Faktor ehf.
Number: 13
Paid: 27.9.2022
Expires: 14.10.2023
Payer: Árnason Faktor ehf.
Number: 14
Paid: 11.10.2023
Expires: 14.10.2024
Payer: Árnason Faktor ehf.
Number: 15
Paid: 23.9.2024
Expires: 14.10.2025
Payer: Árnason Faktor ehf.
Number: 16
Paid: 2.10.2025
Expires: 14.10.2026
Payer: Árnason Faktor ehf.